Used in the treatment of inflammatory skin conditions such as psoriasis, this antibody targets and neutralizes interleukin-22 (IL-22), a cytokine involved in skin inflammation and abnormal cell growth. By blocking IL-22 activity, it helps reduce skin thickening, redness, and scaling. It has also been investigated for use in other immune-mediated diseases including rheumatoid arthritis and inflammatory bowel disease. Clinical trials have shown potential in improving disease symptoms and quality of life in patients with moderate to severe psoriasis.